| 幹細胞特集 |
 |
幹細胞関連の
レポートをご紹介いたします。 |
|
|
|
【 英文市場調査報告書 】
ナノ構造材料市場:バイオメディカル/医薬品/化粧品分野における可能性
Opportunities in Nanostructured Materials: Biomedical, Pharmaceutical and Cosmetic
|
|
|
|
|
 |
 |
※この商品は英文にてご提供いたします。 |
INTRODUCTION
REASON FOR STUDY AND ITS IMPORTANCE
"Nano-", once a seldom-used prefix found in the back of scientific
textbooks, has moved into the industrial mainstream. Literally, "nano"
represents 0.000000001, or 10-9, an extremely small quantity with enormous
implications for the miniaturization-driven technology of the twenty-first
century. Within the past two decades, a variety of terms sharing the prefix
"nano-", such as nanoparticle, nanomaterial, nanophase, and
nanostructured, have emerged to describe certain materials, technologies, and
even businesses; in fact, several firms listed on the NASDAQ stock exchange use
the prefix "nano-" in their company names. Although nano may not yet
be a household word, it is indeed well known within (and increasingly vital to)
the advanced materials community and high-technology business sector. In part
due to the credibility and visibility imparted by the National Nanotechnology
Initiative in early 2000, nanoterminology has become trendy, popular, and
representative of all that is high-tech in the materials world.
In 1997, Business Communications Co., Inc. (BCC) published a seminal
technical-market study of the nanomaterials field ? A report that defined the
scope of the industry for the first time. Since then, the industry has witnessed
many changes: new entrants into the business; production scale-up efforts; new
commercialization strategies; and technological advancements. In light of these
developments, BCC opted to take a fresh look at the industry and reevaluate the
existing and potential markets for nanoparticulate materials. The culmination of
that research is a three-volume series of reports ? Without question the most
comprehensive source of industry information and technical market data available
today on nanoparticulate materials.
OBJECTIVES OF THIS STUDY AND ITS CONTRIBUTION
This study fills a gap in the published literature on nanoparticles and
nanostructured materials. Although numerous technical papers and overview
articles address various aspects of nanomaterial technology, the literature
lacks a comprehensive, up-to-date, and realistic technical market assessment of
nanomaterials over a broad range of applications. This report, GM-201B, which is
part two of a three-volume series, examines in detail biomedical,
pharmaceutical, and cosmetic applications for nanoparticulate materials. The
primary objectives of this study are to provide technological background,
detailed industry information, and market data and forecasts through 2005,
segmented by application and material type.
AUDIENCE FOR THIS REPORT
This report is a valuable resource for companies and organizations that are:
involved in the commercialization of nanoparticulate materials and looking
for new market opportunities;
interested in incorporating nanoparticles into new or existing products as an
end user;
involved in nanomaterial research and development;
in search of licensing opportunities for their nanoparticle synthesis or
processing technologies;
seeking partners for their commercialization efforts; and/or are
looking for venture capital investment opportunities.
SCOPE AND CONTENT OF THIS REPORT
Defined broadly, the term "nanostructured" is used to describe
materials characterized by structural features of less than 100 nm in average
size. All of the materials discussed in this report are inorganic particulate
materials of submicron or nanoscale crystallite sizes. Nanoparticulate ceramics,
metals, alloys, and semiconductors in the form of dry powders, liquid
dispersions, coatings, and bulk materials are considered. Carbon black powders,
fullerenes, and nanotubes are beyond the scope of this study, as are polymeric
nanoparticles. Nanotechnology, the building of components atom by atom, and
micromachines are not covered here.
The report begins with an Overview chapter that describes the various types
and forms of nanostructured materials and their properties, and the surprisingly
extensive history of the industry is detailed in a timeline. The Technology
chapter presents an overview of vapor phase, wet-chemical, and solid-state
techniques in producing nanostructured particles, as well as dispersion,
coating, compaction, and self-assembly technologies. Major researchers and
institutions involved in nanoparticle studies are identified, and the chapter
concludes with an analysis of nanomaterials-related U.S. patents issued during
the past 2 years.
The Industry Structure chapter presents a who's-who of the nanomaterials
industry. Major and minor companies from the U.S. and around the world are
identified and profiled, and nanoparticulate products, pricing,
commercialization strategies and competition are discussed. The chapter
concludes with the identification of industrial recipients of nanomaterials-related
government funding awards during the past decade and a detailed collection of
company profiles.
In the World Markets chapter, current and emerging biomedical,
pharmaceutical, and cosmetic applications for nanoparticles are identified and
analyzed. Within each application area, technological requirements, relevant
production technology, companies involved, and the commercial status are
discussed. Finally, world markets for nanoparticles in each application area are
presented through 2005.
Appendices provide listings of contact information for all of the industry
participants, as well as detailed timelines of industry events (including
company foundings, moves, expansions, acquisitions, and collaborations),
relevant U.S. patent data, and government funding awards.
METHODOLOGY AND INFORMATION SOURCES
The data in this report were obtained from both primary and secondary
sources. Executives, engineers, managers, researchers, and salespeople from
companies and research institutions involved in the development, production,
and/or usage of nanostructured materials were interviewed in the course of this
study. Other data were obtained from an exhaustive review of patent literature
and government databases, as well as scientific, trade, and business journals,
and company literature. BCC newsletters, reports, and conferences provided
additional information.
ANALYST CREDENTIALS
Mindy N. Rittner, Ph.D., the author of this report, has been studying
nanoparticulate materials for nearly a decade, initially as a materials
researcher and more recently as a market analyst. In addition to nanomaterials,
Rittner follows other growing segments of the materials industry, including
metal matrix composites, powder metallurgy, and sputtering target materials. She
is the founder and editor of BCC's monthly newsletter, Nanoparticle News, and
the program chairwoman of BCC's annual nanopowder conference. Rittner earned her
Ph.D. from the Department of Materials Science at Northwestern University.
- REASON FOR STUDY AND ITS IMPORTANCE
- OBJECTIVES OF THIS STUDY AND ITS CONTRIBUTION
- SCOPE AND CONTENT OF THIS REPORT
- METHODOLOGY AND INFORMATION SOURCES
EXECUTIVE SUMMARY
OVERVIEW
TECHNOLOGY
- Gas Condensation with Thermal Evaporation
- Vacuum Evaporation on Running Liquids (VERL)
- Mechanochemical Synthesis
- PRODUCING STABLE DISPERSIONS
- PRODUCTION OF COATINGS, COMPONENTS, AND DEVICES
- Electrophoretic Deposition
- Comparison to Vapor-Deposition Techniques
- DIRECT PRODUCTION OF NANOSTRUCTURED COATINGS AND BULK SOLIDS
- Amorphous Crystallization
- Severe Plastic Deformation
- CONSOLIDATION OF NANOPARTICLES INTO COMPONENTS
- Dynamic-Magnetic Consolidation
- Field-Assisted Sintering Techniques
- Quasi-Isostatic Pressure Process
- SELF-ASSEMBLY OF NANOPARTICLES
- 腺ricks-and-Mortar・Approach
Orders Gold Particles
- Micelles Enable Assembly of Nanolaminates
- Viral Biotemplate Organizes Nanometal Particles into Arrays
- Magnetic Nanoparticle Dispersions Self-Assemble into Ordered Arrays
- MAJOR PLAYERS IN RESEARCH AND DEVELOPMENT
- Trends by Emphasis: Production Versus Application
INDUSTRY STRUCTURE
- COMMERCIALIZATION STRATEGIES
- INTERNATIONAL COMPETITION
- THE ADVANCED TECHNOLOGY PROGRAM
- SMALL BUSINESS INNOVATION RESEARCH (SBIR) AND SMALL BUSINESS TECHNOLOGY
TRANSFER (STTR) PROGRAMS
- ADVANCED POWDER TECHNOLOGY PTY, LTD.
- ALTAIR TECHNOLOGIES, INC.
- ADVANCED POWDER (AP) MATERIALS, INC.
- BAIKOWSKI INTERNATIONAL CORP.
- CABOT MICROELECTRONICS CORP.
- CONDUCTING MATERIALS CORP.
- EKA CHEMICALS
・COLLOIDAL
SILICA GROUP
- IDAHO TITANIUM TECHNOLOGIES, INC.
- INVEST-TECHNOLOGIES, LTD.
- JOHNSON MATTHEY COLOURS & COATINGS DIVISION
- MALAKOFF INDUSTRIES, INC.
- MICROMOD PARTIKELTECHNOLOGIE GMBH
- NANOCRYSTALS TECHNOLOGY, LTD.
- NANOMATERIALS RESEARCH CORP.
- NANOPHASE TECHNOLOGIES CORP.
- NANOPOWDER ENTERPRISES, INC.
- NANOPOWDERS INDUSTRIES, INC.
- NANOSOURCE TECHNOLOGIES, INC.
- NANOSCALE MATERIALS, INC.
- NISSAN CHEMICAL INDUSTRIES, LTD.
- NYACOL NANO TECHNOLOGIES, INC.
- NYMOX PHARMACEUTICAL CORP.
- PRAXAIR SURFACE TECHNOLOGIES, INC.
- SUMITOMO OSAKA CEMENT CO., LTD.
- SUPERCONDUCTIVE COMPONENTS, INC.
- UM RESEARCH NORTH AMERICA
- VACUUM METALLURGICAL CO., LTD.
WORLD MARKETS
- MARKET SEGMENTATION BY APPLICATION
- Segmentation in Terms of Value
- Segmentation in Terms of Volume
- MARKET SEGMENTATION BY MATERIAL TYPE
- Segmentation in Terms of Value
- Segmentation in Terms of Volume
- Materials, Production, and Technical Requirements
- Commercial and Regulatory Status
- BIOLOGICAL DETECTION AND LABELING
- Materials, Production, and Technical Requirements
- Commercial and Regulatory Status
- Emerging Technologies and Applications
- New Technological Developments
- Continuous-Flow Process Yields Nanocrystals for Biodetection
- Materials, Production, and Technical Requirements
- Commercial and Regulatory Status
- Materials, Production, and Technical Requirements
- Commercial and Regulatory Status
- MAGNETIC RESONANCE IMAGING (MRI) CONTRAST AGENTS
- Materials, Production, and Technical Requirements
- Commercial and Regulatory Status
- Materials, Production, and Technical Requirements
- Commercial and Regulatory Status
- New Technological Developments
- Implant Coatings Formed in Low-Energy Process
- High-Strength Bioceramic Obtained from Hydroxyapatite Nanopowders
- SUNSCREENS AND UV-PROTECTIVE COSMETICS
- Materials, Production, and Technical Requirements
- Commercial and Regulatory Status
- Recent Technological Developments
- Hydrothermal Process To Form Rutile TiO2 Advanced by DuPont
- Coated Particles Exhibit Dispersion Stability Even at High Loading
Levels
APPENDIX A: COMPANY CONTACT INFORMATION
- ADVANCED POWDER TECHNOLOGY PTY, LTD.
- ALTAIR TECHNOLOGIES, INC.
- ADVANCED POWDER (AP) MATERIALS, INC.
- BAIKOWSKI INTERNATIONAL CORP.
- CABOT MICROELECTRONICS CORP.
- CONDUCTING MATERIALS CORP.
- DUPONT AIR PRODUCTS NANOMATERIALS, LLC
- IDAHO TITANIUM TECHNOLOGIES, INC.
- MAGNETIC MATERIALS DIVISION
- MALAKOFF INDUSTRIES, INC.
- MICROMOD PARTIKELTECHNOLOGIE GMBH
- NANOMATERIALS RESEARCH CORP.
- NANOPHASE TECHNOLOGIES CORP.
- NANOPOWDER ENTERPRISES, INC.
- NANOPOWDERS INDUSTRIES, INC.
- NANOSOURCE TECHNOLOGIES, INC.
- NISSAN CHEMICAL INDUSTRIES, LTD.
- NISSAN CHEMICAL AMERICA CORP.
- NYACOL NANO TECHNOLOGIES, INC.
- NYMOX PHARMACEUTICAL CORP.
- PRAXAIR SURFACE TECHNOLOGIES, INC.
APPENDIX B: COMPANY FOUNDINGS, ACQUISITIONS, AND MERGERS
APPENDIX C: COMPANY MOVES AND EXPANSIONS
APPENDIX D: COLLABORATIONS AND TECHNOLOGY TRANSFER
APPENDIX E: RELEVANT U.S. PATENTS ISSUED FROM SEPTEMBER 1, 1998 TO SEPTEMBER
1, 2000
APPENDIX F: GOVERNMENT FUNDING AWARDS
APPENDIX G: REFERENCES AND ENDNOTES
LIST OF TABLES
SUMMARY TABLE:
TOTAL WORLD MARKET FOR NANOPARTICLES IN BIOMEDICAL, PHARMACEUTICAL AND
COSMETIC APPLICATIONS, THROUGH 2005
1 SUMMARY OF PROPERTY CHANGES AT THE NANOCRYSTALLINE-SIZE SCALE
2 GENERAL REQUIREMENTS FOR A COMMERCIALLY VIABLE NANOPARTICLE PRODUCTION
METHOD
3 OVERVIEW OF NANOPARTICLE PRODUCTION METHODS
4 PARTICLE PRODUCTION TECHNOLOGIES AND COMPANIES USING THEM
5 STEPS IN THE DISPERSION PROCESS
6 COMPARISON OF COATING TECHNOLOGIES
7 MAJOR PLAYERS IN NANOCRYSTALLINE MATERIAL RESEARCH AND DEVELOPMENT IN THE
U.S. AND CANADA
8 COMPANIES AND INSTITUTIONS AWARDED THREE OR MORE NANOMATERIAL-RELATED
PATENTS
9 COMPANIES WORLDWIDE INVOLVED IN NANOPARTICLE DEVELOPMENT OR PRODUCTION
10 NANOMATERIALS COMPANIES WITH ROOTS IN ACADEMIC OR GOVERNMENT LABORATORIES
11 FACTORS THAT IMPACT THE PRICING OF NANOPARTICLES
12 NANOMATERIAL-RELATED ADVANCED TECHNOLOGY PROGRAM AWARDS, THROUGH 2000
13 RECIPIENTS OF THREE OR MORE NANOMATERIALS-RELATED PHASE I SBIR/STTR
AWARDS, THROUGH 1999
14 WORLD MARKETS FOR NANOPARTICLES IN BIOMEDICAL, PHARMACEUTICAL, AND
COSMETIC APPLICATIONS; SEGMENTATION BY APPLICATION IN TERMS OF VALUE, THROUGH
2005
15 WORLD MARKETS FOR NANOPARTICLES IN BIOMEDICAL, PHARMACEUTICAL, AND
COSMETIC APPLICATIONS, SEGMENTATION BY APPLICATION IN TERMS OF VOLUME, THROUGH
2005
16 WORLD MARKETS FOR NANOPARTICLES IN BIOMEDICAL, PHARMACEUTICAL AND
COSMETIC APPLICATIONS, SEGMENTATION BY MATERIAL TYPE IN TERMS OF VALUE,
THROUGH 2005
17 WORLD MARKETS FOR NANOPARTICLES IN BIOMEDICAL, PHARMACEUTICAL, AND
COSMETIC APPLICATIONS, SEGMENTATION BY MATERIAL TYPE IN TERMS OF VOLUME,
THROUGH 2005
18 REQUIREMENTS FOR ANTIMICROBIAL COATINGS
19 TIMELINE OF REGULATORY APPROVALS FOR WESTAIM BIOMEDICAL担
ANTIMICROBIAL SILVER FILMS
20 REPRESENTATIVE ANTIMICROBIAL PRODUCTS UNDERGOING COMMERCIALIZATION
21 WORLD MARKETS FOR NANOPARTICLES IN ANTIMICROBIAL SILVER APPLICATIONS,
THROUGH 2005
22 BASIC REQUIREMENTS OF DIAGNOSTIC TESTS
23 RAPID DIAGNOSTIC TESTS THAT USE GOLD NANOPARTICLES AS LABELS
24 COMPANIES DEVELOPING NANOPARTICULATE PRODUCTS FOR BIODETECTION AND
LABELING
25 COMPARISON BETWEEN QUANTUM DOT CORPORATION担 QDOTS
AND CONVENTIONAL ORGANIC DYES
26 COMPARISON OF THE VARIOUS TYPES OF NANOPARTICLE LABELS UNDER DEVELOPMENT
27 WORLD MARKETS FOR NANOPARTICLES IN BIODETECTION AND LABELING
APPLICATIONS, THROUGH 2005
28 PRODUCERS OF SUPERPARAMAGNETIC MICROSPHERES FOR BIOLOGICAL SEPARATION
APPLICATIONS
29 WORLD MARKETS FOR NANOPARTICLES IN BIOMAGNETIC SEPARATIONS, THROUGH 2005
30 CRITERIA FOR A PARTICULATE DRUG DELIVERY VEHICLE
31 COMPANIES ACTIVE IN THE DEVELOPMENT OF INORGANIC PARTICLES FOR
DRUG-DELIVERY APPLICATIONS
32 STATUS OF COMPANIES DEVELOPING DRUG-CARRIER TECHNOLOGIES
33 WORLD MARKETS FOR NANOPARTICLES IN DRUG-DELIVERY APPLICATIONS, THROUGH
2005
34 TYPES OF CONTRAST AGENTS USED FOR MRI IMAGING
35 SUPERPARAMAGNETIC IRON OXIDE CONTRAST MEDIA: REGULATORY AND MARKETING
STATUS
36 SALES OF MRI CONTRAST MEDIA, THROUGH 2004
37 MRI CONTRAST MEDIA SALES BY APPLICATION, THROUGH 2004
38 ADVANCED MAGNETICS・PRODUCT
SALES AND OTHER REVENUE, 1995-2000
39 WORLD MARKETS FOR IRON OXIDE NANOPARTICLES AS MRI CONTRAST AGENTS,
THROUGH 2005
40 COMPANIES ACTIVE IN DEVELOPING NANOPARTICLE-BASED BIOACTIVE CERAMICS
41 COMPETITION FOR SYNTHETIC BONE SUBSTITUTES
42 WORLD MARKETS FOR NANOPARTICLES IN ORTHOPEDIC APPLICATIONS, THROUGH 2005
43 SUNSCREEN INORGANIC AND ORGANIC ACTIVE INGREDIENTS
44 TECHNICAL REQUIREMENTS FOR NANOPARTICLES IN UV-SHIELDING APPLICATIONS
45 PRODUCERS OF TITANIUM DIOXIDE AND ZINC OXIDE PARTICLES AND DISPERSIONS
46 SUN-CARE AND DAILY CARE PRODUCTS THAT CONTAIN NANOPARTICULATE ZINC OXIDE
OR TITANIUM DIOXIDE*
47 WORLD MARKET SHARES OF SUNSCREEN MANUFACTURERS, 1998
48 WORLD MARKETS FOR NANOPARTICLES IN SUNSCREEN APPLICATIONS, THROUGH 2005
49 COMPANY FOUNDINGS, ACQUISITIONS AND MERGERS
50 COMPANY MOVES AND EXPANSIONS
51 COLLABORATIONS AND TECHNOLOGY TRANSFER
52 COMPILATION OF U.S. PATENTS
53 RELEVANT SBIR AND STTR AWARDS SPONSORED BY THE DEPARTMENT OF DEFENSE,
1997 TO 2000
54 RELEVANT SBIR AND STTR AWARDS FROM 1991 TO 1996
LIST OF FIGURES
SUMMARY FIGURE:
TOTAL WORLD MARKET FOR NANOPARTICLES IN BIOMEDICAL, PHARMACEUTICAL AND
COSMETIC APPLICATIONS, 2000 AND 2005
1 QUALITATIVE DEPENDENCE OF MAGNETIC COERCIVITY (Hc) ON ULTRAFINE PARTICLE
SIZE
2 TIMELINE OF INDUSTRY EVENTS
3 SCHEMATIC OF THE MODIFIED VERL PROCESS TO PRODUCE METAL NANOSUSPENSIONS
4 SOL-GEL SYNTHESIS FLOW CHART
5 U.S. PATENT TRENDS BY COUNTRY
6 SHARES OF U.S. PATENTS BY ASSIGNEE
7 SHARES OF PATENTS ISSUED BY EMPHASIS
8 PATENT BREAKDOWN BY APPLICATION
9 WORLD MARKET FOR NANOPARTICLES IN BIOMEDICAL, PHARMACEUTICAL AND COSMETIC
APPLICATIONS, 2000 AND 2005
10 SHARES OF THE WORLD MARKET FOR NANOPARTICLES BY APPLICATION, 2000 AND
2005
11 SHARES OF THE WORLD MARKET FOR NANOPARTICLES BY MATERIAL TYPE, 2000 AND
2005
12 WORLD MARKETS FOR NANOPARTICLES IN ANTIMICROBIAL APPLICATIONS, 2000 AND
2005
13 WORLD MARKETS FOR NANOPARTICLES IN BIODETECTION AND LABELING, 2000 AND
2005
14 SHARES OF THE BIOLABELING MARKET BY MATERIAL TYPE, 2000 AND 2005
15 WORLD MARKETS FOR NANOPARTICLES IN MAGNETIC SEPARATIONS, 2000 AND 2005
16 TIMELINE OF NEW-DRUG DEVELOPMENT PROCESS
17 WORLD MARKETS FOR IRON OXIDE NANOPARTICLES IN MRI IMAGING, THROUGH 2005
18 WORLD MARKETS FOR NANOPARTICLES IN ORTHOPEDIC APPLICATIONS, 2000 AND 2005
19 WORLD MARKETS FOR NANOPARTICLES IN SUNSCREEN APPLICATIONS, 2000 AND 2005
20 SHARES OF THE SUN-CARE MARKET BY MATERIAL TYPE, 2000 AND 2005
|
 |
 |
※この商品は英文にてご提供いたします。 |
|
【 英文市場調査報告書 】
ナノ構造材料市場:バイオメディカル/医薬品/化粧品分野における可能性
Opportunities in Nanostructured Materials: Biomedical, Pharmaceutical and Cosmetic
出版日 : 2001/08
|
|
|
|
|
|
※ドル建て価格の商品のお支払いは、為替レート (TTS: 93.78)
換算による円建てのご請求書にて承ります。
|
商品コード : 8285 |
|
|
|
|
|
|
バイオテクノロジー
その他のカテゴリ
FAQ